|
|
| Catalog Number |
94154 |
| Medical Device Problem Code |
Migration (4003)
|
| Health Effect - Clinical Code |
Inflammation (1932)
|
| Date of Event |
06/02/2026
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Clarification to h.6.Type of investigation code: the filler was injected into the patient and is not accessible for return.The syringe was not returned for evaluation.The event is a physiological complication and analysis of the device generally does not assist abbvie in determining a probable cause for this event.Further information regarding event, product, or patient details has been requested.No additional information is available at this time.A review of the device history record has been initiated.If any new, changed or corrected information is noted, a supplemental medwatch will be submitted.This is a known potential adverse event addressed in the product labeling.
|
| |
|
Event or Problem Description
|
|
Healthcare professional reported a patient was injected with 1cc of juvéderm® ultra xc into the nlfs and then roughly two weeks later, patient reported they had a nodule on the left side.Upon examination of patient, it was determined not to be a nodule, rather a slight induration likely caused by filler migration.15-20 units of hylenex were injected into the area and patient was massaged.Area was much improved following this, but events still ongoing.
|
| |
|
Search Alerts/Recalls
|
|
|